Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • market

    Tag: market

    You Searched For "market"
    Zydus gets regulatory nod to market Lipaglyn in Mexico

    Zydus gets regulatory nod to market Lipaglyn in Mexico

    Ruby Khatun Khatun11 Nov 2017 10:32 AM IST
    New Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
    To market new drugs in India, global trials must include Indians

    To market new drugs in India, global trials must include Indians

    Ruby Khatun Khatun12 Oct 2017 3:21 PM IST
    New Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
    US pressing India to avoid capping medical device prices, allow withdrawals

    US pressing India to avoid capping medical device prices, allow withdrawals

    Ruby Khatun Khatun6 Oct 2017 10:33 AM IST
    New Delhi: The United States is pressing India not to extend price caps on medical devices and wants the government to allow firms to withdraw...
    Zydus gets USFDA nod for overactive bladder drug

    Zydus gets USFDA nod for overactive bladder drug

    Ruby Khatun Khatun6 Oct 2017 9:49 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Ruby Khatun Khatun5 Oct 2017 10:17 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
    Lupin gets USFDA nod for generic version of Clobex lotion

    Lupin gets USFDA nod for generic version of Clobex lotion

    Ruby Khatun Khatun27 Sept 2017 12:43 PM IST
    New Delhi: Drug maker Lupin said it has received approval from the US health regulator to market anti-inflammatory Clobetasol Propionate lotion in the...
    US tribal patent deal could have big impact on generic drug market

    US tribal patent deal could have big impact on generic drug market

    Ruby Khatun Khatun14 Sept 2017 9:45 AM IST
    A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be...
    Lupin gets USFDA nod to market anti-infections tablets

    Lupin gets USFDA nod to market anti-infections tablets

    Ruby Khatun Khatun12 Sept 2017 10:21 AM IST
    New Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...
    Yakult Danone to launch new probiotic products

    Yakult Danone to launch new probiotic products

    Ruby Khatun Khatun10 Sept 2017 11:06 AM IST
    New Delhi: Yakult Danone, the manufacturer of milk-based fermented probiotic drinks, might consider the launch of new products in the Indian market...
    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity

    Ruby Khatun Khatun28 Aug 2017 1:05 PM IST
    FRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
    Three healthcare-focused funds keen to pick minority stake in Morpheus IVF

    Three healthcare-focused funds keen to pick minority stake in Morpheus IVF

    Ruby Khatun Khatun14 Aug 2017 9:25 AM IST
    MUMBAI: Morpheus IVF wants to sell a minority stake for which it has attracted the interest of major healthcare-focused funds Quadria Capital, Asian...
    Zydus Cadila gets USFDA nod to market HIV drug

    Zydus Cadila gets USFDA nod to market HIV drug

    Ruby Khatun Khatun10 Aug 2017 9:30 AM IST
    New Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok